JSW EV/EBIT
¿Qué es el EV/EBIT de JSW?
El EV/EBIT de JSW Holdings Limited es 26.03
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Finance en BSE en comparadas con JSW
¿Qué hace JSW?
JSW Holdings Limited, a non-banking financial company, engages in investing and financing activities. The company was formerly known as Jindal South West Holdings Limited and changed its name to JSW Holdings Limited in 2013. JSW Holdings Limited was incorporated in 2001 and is based in Mumbai, India.
Empresas con ev/ebit similar a JSW
- McDowell tiene EV/EBIT de 25.98
- I3 Plc tiene EV/EBIT de 26.00
- Western Asset Investment Grade Income Fund Inc tiene EV/EBIT de 26.01
- Oxford Metrics Plc tiene EV/EBIT de 26.02
- Henderson Land Development Co tiene EV/EBIT de 26.02
- Lam Research tiene EV/EBIT de 26.03
- JSW tiene EV/EBIT de 26.03
- Old Dominion Freight Line tiene EV/EBIT de 26.04
- RH tiene EV/EBIT de 26.04
- Xcel tiene EV/EBIT de 26.04
- NIKE tiene EV/EBIT de 26.05
- BlackRock MuniYield New Jersey Fund Inc tiene EV/EBIT de 26.06
- Regeneron Pharmaceuticals tiene EV/EBIT de 26.09